Hims & Hers director exercises 14,343 share units

Hims & Hers Health, Inc. director Christopher D. Payne exercised restricted stock unit awards into a total of 14,343 shares of Class A Common Stock in June 2026, all at a price of $0.00 per share.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Hims & Hers Health, Inc. director Christopher D. Payne exercised restricted stock unit awards into a total of 14,343 shares of Class A Common Stock in June 2026, all at a price of $0.00 per share. These are compensation-related derivative exercises rather than open‑market purchases or sales.

After the transactions, he holds 34,318 shares directly and 110,000 shares indirectly through The Payne Family Trust dated September 17, 2020. Some RSUs remain outstanding, including 10,040 units granted in lieu of $14,875 of first‑quarter 2026 director and committee cash fees, calculated at a grant price of $22.98 per share and scheduled to vest on the company’s next quarterly vesting date.

Insider Trade Summary

14,343 shares exercised/converted

Exercise 7 txns

Insider Payne Christopher D

Role Director

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Unit	10,040	$0.00	$0.00
Exercise	Restricted Stock Unit	647	$0.00	$0.00
Exercise	Class A Common Stock	10,040	$0.00	$0.00
Exercise	Class A Common Stock	647	$0.00	$0.00
Exercise	Restricted Stock Unit	3,656	$0.00	$0.00
Exercise	Class A Common Stock	3,656	$0.00	$0.00
holding	Class A Common Stock	--	--	--

Holdings After Transaction: Restricted Stock Unit — 10,040 contracts (Direct); Class A Common Stock — 34,318 shares (Direct); Class A Common Stock — 110,000 shares (Indirect, Held by The Payne Family Trust dtd 09/17/2020)

Footnotes (4)

F1. The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. Subject to continuous service, the RSUs will vest on the earlier of (a) the date of the 2026 annual meeting of stockholders or (b) June 15, 2026.
F2. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 3-year period, with : (i) 1/3 of the RSUs vesting on June 15, 2025, (ii) 1/3 of the RSUs vesting on June 15, 2026, and (iii) 1/3 of the RSUs vesting on May 15, 2027.
F3. The RSUs were issued to the Reporting Person pursuant to the Issuer's Director Compensation Policy, in lieu of the director retainer and committee membership fees for the first quarter of 2026. The number of RSUs granted was calculated by dividing the foregone cash fees of $14,875 by the grant price of $22.98. The RSUs will vest in full on the Company's next quarterly vesting date.
F4. The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.

Key Figures

Shares from RSU exercises: 14,343 shares Direct holdings after exercises: 34,318 shares Indirect trust holdings: 110,000 shares +4 more

7 metrics

Shares from RSU exercises 14,343 shares Total shares acquired via derivative exercises reported in June 2026

Direct holdings after exercises 34,318 shares Class A Common Stock held directly by Christopher Payne after transactions

Indirect trust holdings 110,000 shares Class A Common Stock held by The Payne Family Trust dtd 09/17/2020

Fee-replacement cash amount $14,875 First-quarter 2026 director and committee fees converted into RSUs

RSU grant price $22.98 per share Price used to convert $14,875 of cash fees into 10,040 RSUs

Outstanding fee-replacement RSUs 10,040 RSUs Restricted stock units granted in lieu of Q1 2026 cash fees

Three-year RSU vesting tranches 1/3 each on Jun 15 2025, Jun 15 2026, May 15 2027 Service-based RSU vesting schedule

Key Terms

Restricted Stock Unit, Director Compensation Policy, contingent right, service-based vesting requirement, +1 more

5 terms

Restricted Stock Unit financial

"The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU."

A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.

Director Compensation Policy financial

"The RSUs were issued to the Reporting Person pursuant to the Issuer's Director Compensation Policy, in lieu of the director retainer and committee membership fees for the first quarter of 2026."

contingent right financial

"The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU."

service-based vesting requirement financial

"The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 3-year period."

annual meeting of stockholders financial

"the RSUs will vest on the earlier of (a) the date of the 2026 annual meeting of stockholders or (b) June 15, 2026."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did HIMS director Christopher D. Payne report in this Form 4?

Christopher D. Payne reported exercising restricted stock unit awards into 14,343 shares of Hims & Hers Class A Common Stock. These derivative exercises are compensation-related events, not open‑market stock purchases or sales, and increase his directly held share position in the company.

How many Hims & Hers (HIMS) shares does Christopher Payne hold after these transactions?

After the reported exercises, Christopher Payne holds 34,318 Hims & Hers Class A Common shares directly. He also has an indirect position of 110,000 shares held through The Payne Family Trust dated September 17, 2020, giving a combined substantial equity exposure reported in this Form 4.

What is the size and pricing of the RSU grant taken in lieu of cash fees at HIMS?

One RSU grant replaced $14,875 of first‑quarter 2026 director and committee cash fees at a grant price of $22.98. This calculation produced 10,040 restricted stock units, which each represent a contingent right to receive one Hims & Hers Class A Common share upon vesting.

What are the vesting terms for Christopher Payne’s Hims & Hers RSUs?

The filing describes RSUs with service-based vesting. One award vests on the earlier of the 2026 annual stockholders’ meeting or June 15, 2026. Another three‑year award vests in equal one‑third installments on June 15, 2025, June 15, 2026, and May 15, 2027, assuming continuous service.

How are Christopher Payne’s RSUs at Hims & Hers structured?

Each restricted stock unit represents a contingent right to receive one share of Hims & Hers Class A Common Stock. Certain RSUs were granted under the company’s Director Compensation Policy, replacing cash retainers, and will vest on specified future dates subject to his continued service.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 06/15/2026 - 05:13 PM EDT

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Payne Christopher D

(Last)

(First)

(Middle)

2269 CHESTNUT STREET, #523

(Street)

SAN FRANCISCO

CALIFORNIA

94123

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Hims & Hers Health, Inc. [ HIMS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/11/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Class A Common Stock	06/11/2026		M		3,656	A	⁽¹⁾	23,631	D
Class A Common Stock	06/15/2026		M		10,040	A	⁽²⁾	33,671	D
Class A Common Stock	06/15/2026		M		647	A	⁽³⁾	34,318	D
Class A Common Stock								110,000	I	Held by The Payne Family Trust dtd 09/17/2020

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Restricted Stock Unit	⁽¹⁾	06/11/2026		M			3,656	⁽¹⁾	⁽¹⁾	Class A Common Stock	3,656	$0	0	D
Restricted Stock Unit	⁽⁴⁾	06/15/2026		M			10,040	⁽²⁾	⁽²⁾	Class A Common Stock	10,040	$0	10,040	D
Restricted Stock Unit	⁽⁴⁾	06/15/2026		M			647	06/15/2026	⁽³⁾	Class A Common Stock	647	$0	0	D

Explanation of Responses:

1. The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. Subject to continuous service, the RSUs will vest on the earlier of (a) the date of the 2026 annual meeting of stockholders or (b) June 15, 2026.

2. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 3-year period, with : (i) 1/3 of the RSUs vesting on June 15, 2025, (ii) 1/3 of the RSUs vesting on June 15, 2026, and (iii) 1/3 of the RSUs vesting on May 15, 2027.

3. The RSUs were issued to the Reporting Person pursuant to the Issuer's Director Compensation Policy, in lieu of the director retainer and committee membership fees for the first quarter of 2026. The number of RSUs granted was calculated by dividing the foregone cash fees of $14,875 by the grant price of $22.98. The RSUs will vest in full on the Company's next quarterly vesting date.

4. The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.

Remarks:

	/s/ Kimberly Mather, Attorney-in-Fact for Christopher D Payne	06/15/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR